The Philadelphia Business Journal announced on Wednesday that Betty Long, RN, President and Founder of Guardian Nurses Healthcare Advocates has been honored as a 2011 Women of Distinction Award Recipient.
The region's most dynamic women will be recognized on Tuesday, November 29, 2011 from 5PM to 8:30PM at the Philadelphia Sheraton Hotel, 17th and Race Streets.
The event will gather over 500 of the region's newsmakers for networking and an awards ceremony. Long, along with the other award recipients, will be profiled in a special section of the Business Journal's November 25th issue.
Invisible Sentinel Announces Allowance of Additional U.S. Patent Application for Rapid Diagnostic Technology to Detect Harmful Pathogens in Food
Invisible Sentinel Expands Intellectual Property for Company’s Diagnostic Technology
Philadelphia, Pennsylvania, March 27, 2012 - Invisible Sentinel Inc., a life sciences company that develops rapid diagnostics for the detection of foodborne pathogens, announced today it has been issued a notice of allowance for U.S. Patent application 13/221,116, “Device for Detection of Target Molecules and Uses Thereof.” Once issued, this will be the second U.S. patent for Invisible Sentinel and will serve to further strengthen the Company’s intellectual property position. This application provides additional protection for Invisible Sentinel’s proprietary diagnostic device capable of rapid and selective identification of pathogenic bacteria from contaminated food samples. The Company also has additional patent applications pending both in the United States and abroad.
“The allowance of this patent application is a valuable addition to our Company’s growing intellectual property portfolio,” said Benjamin Pascal, CEO and co-founder of Invisible Sentinel. “Our expanding patent portfolio comes at an opportune time, when new government regulations and enhanced consumer awareness are leading to a significant increase in food pathogen testing throughout the industry. We are currently preparing for regulatory submissions and anticipate commercializing our technology later this year.“
Invisible Sentinel’s diagnostic system provides a robust, sensitive, reproducible, and easy-to-interpret assay. The Company’s internally developed technology is designed to address the growing need for rapid, practical, and cost-efficient detection methods for foodborne pathogens at the point of care. “We anticipate our products to be an important step forward in enabling food processors and third party laboratories to perform practical yet sophisticated testing for pathogen contamination from farm to fork,” said Pascal. The food industry is the first market that the Company is targeting, but its patented and patent pending technology has the potential to provide valuable tools for additional industries including healthcare, veterinary, biodefense, and environmental testing, where rapid detection of target analytes from unrefined samples is critical.
Based in Philadelphia, Invisible Sentinel develops diagnostic technologies for a safer food supply. The Company’s focus is on developing rapid diagnostics that quickly provide accurate information about the presence of harmful pathogens. Uniquely designed for easy, practical use—on-site and throughout the entire food distribution network—Invisible Sentinel’s proprietary diagnostic products promise to create a new standard for rigorous quality control.
Life Sciences Awards
Best Early-Stage Company: Platinum
Invisible Sentinel Inc. | Philadelphia
Invisible Sentinel website
Premium content from Philadelphia Business Journal
Date: Friday, October 7, 2011, 6:00am EDT
Invisible Sentinel was founded in 2006 by Benjamin Pascal, the CEO, and Nicholas Siciliano, the company’s co-founder and chief operating officer, to develop novel, point-of-care diagnostic systems for the detection of microbial pathogens in the food supply. It employs eight in Philadelphia.
Major milestones: To date, Invisible Sentinel has recruited talented and accomplished scientists, raised $4 million from angel investors, and received its first patent, on Sept. 6, 2011. The company was selected by the U.S. and Chinese governments to travel to China as part of an envoy of diagnostic experts to explore methods to improve food quality and safety in China. The company has agreements from manufacturers and processors to alpha/beta test products and has received third party-validations for its diagnostic systems. It has also developed customized diagnostic platforms based on user requirements and field applications. The company has established an animal facility at The University of the Sciences and attracted interest from several potential strategic partners.
Top company goals for 2012: Invisible Sentinel is looking forward to launching its food-borne diseases diagnostic portfolio in 2012. The company intends to continue to explore out-licensing and strategic partnering opportunities, optimize manufacturing capabilities, scale up marketing and sales strategies and meet 2012 revenue projections.